Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FT.3.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FT.3.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.3.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.3.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.4.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.4.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HS.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HS.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.73ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.73ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.73ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.73NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.8.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.8.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.8.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDRORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDRENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDRENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDRNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used